keyword
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#1
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652317/oral-mucosa-an-examination-map-for-confocal-laser-endomicroscopy-within-the-oral-cavity-an-experimental-clinical-study
#2
JOURNAL ARTICLE
Nicolai Oetter, Jonas Pröll, Matti Sievert, Miguel Goncalves, Maximilian Rohde, Christopher-Philipp Nobis, Christian Knipfer, Marc Aubreville, Zhaoya Pan, Katharina Breininger, Andreas Maier, Marco Kesting, Florian Stelzle
OBJECTIVES: Confocal laser endomicroscopy (CLE) is an optical method that enables microscopic visualization of oral mucosa. Previous studies have shown that it is possible to differentiate between physiological and malignant oral mucosa. However, differences in mucosal architecture were not taken into account. The objective was to map the different oral mucosal morphologies and to establish a "CLE map" of physiological mucosa as baseline for further application of this powerful technology...
April 23, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38652038/a-first-in-human-phase-1-study-of-a-tumor-directed-rna-interference-drug-against-hif2%C3%AE-in-patients-with-advanced-clear-cell-renal-cell-carcinoma
#3
JOURNAL ARTICLE
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
PURPOSE: ARO-HIF2 is an siRNA drug designed to selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). The aims of this Phase 1 study (AROHIF21001) were to evaluate safety, tolerability, pharmacokinetics, and establish a recommended Phase 2 dose. PATIENTS AND METHODS: Subjects with ccRCC and progressive disease after at least 2 prior therapies that included VEGF and immune checkpoint inhibitors were progressively enrolled into dose-escalation cohorts of ARO-HIF2 administered intravenously at 225, 525, or 1,050 mg weekly...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38651612/yolk-sac-differentiation-in-endometrial-carcinoma-incidence-and-clinicopathologic-features-of-somatically-derived-yolk-sac-tumors-versus-carcinomas-with-nonspecific-immunoexpression-of-yolk-sac-markers
#4
JOURNAL ARTICLE
Anne M Mills, Taylor M Jenkins, Megan E Dibbern, Kristen A Atkins, Kari L Ring
Endometrial somatically derived yolk sac tumors are characterized by yolk sac morphology with AFP, SALL-4, and/or Glypican-3 immunoexpression. Yolk sac marker expression, however, is not limited to tumors with overt yolk sac histology. Three hundred consecutive endometrial malignancies were assessed for immunomarkers of yolk sac differentiation. Of these, 9% expressed ≥1 yolk sac marker, including 29% of high-grade tumors. Only 3 (1%) met morphologic criteria for yolk sac differentiation; these were originally diagnosed as serous, high-grade NOS, and dedifferentiated carcinoma...
April 23, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38651176/predictive-factors-of-nivolumab-plus-ipilimumab-treatment-efficacy-in-metastatic-renal-cell-carcinoma-patients
#5
JOURNAL ARTICLE
Kojiro Ohba, Hiromi Nakanishi, Ken Kawada, Yuichiro Nakamura, Kensuke Mitsunari, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura
OBJECTIVE: Nivolumab plus ipilimumab is a recommended first-line therapy regimen for metastatic renal cell carcinoma. However, it is not clear which patient characteristics are associated with its effectiveness. METHODS: We retrospectively examined 67 metastatic renal cell carcinoma patients treated with nivolumab plus ipilimumab as a first-line therapy in multiple institutions from September 2018 to August 2022. We analyzed the relationships between survival outcomes and patient-related variables, including paraneoplastic symptoms...
April 22, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38651150/sunitinib-for-adenocarcinoma-of-the-rete-testis-a-case-report
#6
Kezhen Li, Di Chen, Mingdong He, Jun Yu, Hua Mi
BACKGROUND: Adenocarcinoma of the rete testis (AORT) is an extremely rare and aggressive tumor with a poor prognosis. Its etiology and pathological characteristics have not been extensively studied, making accurate diagnosis and appropriate management challenging. AORT, an invasive testicular tumor with a mortality rate of 46%, treatment typically involves radical orchiectomy, retroperitoneal pelvic lymph node dissection (RPLND), adjuvant chemotherapy, and/or ongoing monitoring, but the response to conventional radiation and chemotherapy is limited...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650412/-modern-view-on-the-problem-of-diagnostics-of-renal-angiomioadenomatous-tumor
#7
JOURNAL ARTICLE
I Osmanov Y, A Kogan E, K Gadzhieva Z, G Radenska-Lopovok S, D Prochenko D
INTRODUCTION: Angiomyoadenomatous tumor as a nosological entity is not included in the latest version of the International Histological Classification of Kidney Tumors (WHO, 2022) and is related to provisional entity. Currently, there is no consensus among researchers about the nosological affiliation of an angiomyoadenomatous tumor. AIM: To comparatively analyze the histological, immunophenotypic, ultrastructural and molecular parameters of renal angiomyoadenomatous tumor and clear cell papillary renal cell tumor...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38650144/comprehensive-bioinformatics-analysis-of-kif20a-as-a-prognosis-biomarker-for-clear-cell-renal-cell-carcinoma
#8
JOURNAL ARTICLE
Cankun Xie, Wingkeung Yiu, Yijiang Mo
It has been shown that kinesin family member 20A (KIF20A) is involved in the development of several cancers. However, research on clear cell renal cell carcinoma (ccRCC) and KIF20A is still exploratory. The current research was carried out to determine whether KIF20A expression has any prognosis value in ccRCC. Data were downloaded from The Cancer Genome Atlas (TCGA) database to validate the KIF20A mRNA expression and to perform clinicopathological analysis. Receiver operating characteristic (ROC) curves were used in evaluating KIF20A's diagnostic performance for ccRCC...
March 31, 2024: Cellular and Molecular Biology
https://read.qxmd.com/read/38649345/med15-is-upregulated-by-hif-2%C3%AE-and-promotes-proliferation-and-metastasis-in-clear-cell-renal-cell-carcinoma-via-activation-of-srebp-dependent-fatty-acid-synthesis
#9
JOURNAL ARTICLE
Xiaoliang Hua, Shengdong Ge, Li Zhang, Qing Jiang, Juan Chen, Haibing Xiao, Chaozhao Liang
Emerging evidence has highlighted that dysregulation of lipid metabolism in clear cell renal cell carcinoma (ccRCC) is associated with tumor development and progression. HIF-2α plays an oncogenic role in ccRCC and is involved in abnormal lipid accumulation. However, the underlying mechanisms between these two phenomena remain unknown. Here, MED15 was demonstrated to be a dominant factor for HIF-2α-dependent lipid accumulation and tumor progression. HIF-2α promoted MED15 transcriptional activation by directly binding the MED15 promoter region, and MED15 overexpression significantly alleviated the lipid deposition inhibition and malignant tumor behavior phenotypes induced by HIF-2α knockdown...
April 22, 2024: Cell Death Discovery
https://read.qxmd.com/read/38648945/cost-effectiveness-analysis-of-the-clear-cell-likelihood-score-against-renal-mass-biopsy-for-evaluating-small-renal-masses
#10
JOURNAL ARTICLE
Katherina Y Chen, Moritz J Lange, Jessica X Qiu, Drew Lambert, Ayman Mithqal, Tracey L Krupski, Noah S Schenkman, Jennifer M Lobo
OBJECTIVE: To examine the cost-effectiveness of the clear cell likelihood score compared to renal mass biopsy alone. METHODS: The clear cell likelihood score, a new grading system based on multiparametric magnetic resonance imaging, has been proposed as a possible alternative to percutaneous renal mass biopsy for identifying clear cell renal carcinoma in small renal masses and expediting treatment of high-risk patients. A decision analysis model was developed to compare a renal mass biopsy strategy where all patients undergo biopsy and a clear cell likelihood score strategy where only patients that received an indeterminant score of 3 undergo biopsy...
April 20, 2024: Urology
https://read.qxmd.com/read/38648027/follicular-infundibular-tricholemmal-squamous-cell-carcinoma-a-new-who-entity-clinicopathological-features-in-103-cases-including-follow-up-and-implications-for-patient-management
#11
JOURNAL ARTICLE
Richard A Carr, James Wiggins, David N Slater
AIMS: Cutaneous follicular (infundibular-tricholemmal) squamous cell carcinoma (FSCC) is a new World Health Organization entity. We present the largest series of published cases, summarizing clinical data, diagnostic criteria, differential diagnosis, and implications for patient management. METHODS: Cases were identified from 2004 to 2011. Inclusion criteria included discrete attachment(s) of the tumor to the overlying epidermis via follicular infundibula, tricholemmal keratinization, and cellular pleomorphism...
April 23, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38647434/correction-for-mtdh-promotes-metastasis-of-clear-cell-renal-cell-carcinoma-by-activating-snd1-mediated-erk-signaling-and-epithelial-mesenchymal-transition
#12
JOURNAL ARTICLE
Anbang He, Shiming He, Cong Huang, Zhicong Chen, Yucai Wu, Yanqing Gong, Xuesong Li, Liqun Zhou
No abstract text is available yet for this article.
April 15, 2024: Aging
https://read.qxmd.com/read/38646445/window-of-opportunity-with-pd1-blockade-before-chemoradiotherapy-for-an-advanced-stage-clear-cell-carcinoma-of-the-cervix
#13
Marie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, Jean-Christophe Tille, Patrick Petignat, Manuela Undurraga, S Intidhar Labidi-Galy
Clear cell carcinoma is a rare and very aggressive subset of cervical cancer, with poor outcome if diagnosed at advanced stage. There are few data available on the optimal management of this histotype, and treatment recommendations that include surgery and chemoradiotherapy, are essentially based on those for squamous cell carcinoma. Here we report the case of a young patient newly diagnosed with advanced stage (FIGO IIB) clear cell carcinoma of the uterine cervix who received a window of opportunity one injection of nivolumab followed by standard chemoradiotherapy...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38645566/retraction-case-report-a-rare-case-of-tumor-to-tumor-metastasis-metastatic-lobular-breast-carcinoma-to-clear-cell-renal-cell-carcinoma
#14
(no author information available yet)
[This retracts the article DOI: 10.3389/pore.2023.1611204.].
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38644691/comprehensive-analysis-of-n6-methylandenosine-related-lncrnas-in-clear-cell-renal-cell-carcinoma-a-correlation-with-prognosis-tumor-progression-and-therapeutic-response
#15
JOURNAL ARTICLE
Chang Meng, Juan Li, Xiang Wang, Yicen Ying, Zhihua Li, Aixiang Wang, Xuesong Li
This study aims to develop a prognostic signature based on m6A-related lncRNAs for clear cell renal cell carcinoma (ccRCC). Differential expression analysis and Pearson correlation analysis were used to identify m6A-related lncRNAs associated with patient outcomes in The Cancer Genome Atlas (TCGA) database. Our approach led to the development of an m6A-related lncRNA risk score (MRLrisk), formulated using six identified lncRNAs: NFE4, AL008729.2, AL139123.1, LINC02154, AC124854.1 and ARHGAP31-AS1. Higher MRLrisk was identified as a risk factor for patients' prognosis in ccRCC...
April 21, 2024: Cancer Investigation
https://read.qxmd.com/read/38644421/prevotella-intermedia-boosts-oscc-progression-through-isg15-upregulation-a-new-target-for-intervention
#16
JOURNAL ARTICLE
Yao Qin, Zhiyuan Li, Ting Liu, Jingjing Ma, Hong Liu, Yifan Zhou, Shuai Wang, Lei Zhang, Qiao Peng, Pei Ye, Ning Duan, Wenmei Wang, Xiang Wang
PURPOSE: Periodontitis-associated bacteria, such as Porphyromonas gingivalis and Fusobacterium nucleatum, are closely linked to the risk of oral squamous cell carcinoma (OSCC). Emerging studies have indicated that another common periodontal pathogen, Prevotella intermedia (P. intermedia), is enriched in OSCC and could affect the occurrence and progression of OSCC. Our aim is to determine the effects of P. intermedia on the progression of OSCC and the role of antibiotics in reversing these effects...
April 21, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38643380/representation-of-skin-carcinomas-in-public-awareness-awareness-worldwide-and-in-germany
#17
JOURNAL ARTICLE
Anne Meinzenbach, Martin Kaatz, Steffen Springer, Michael Zieger
BACKGROUND AND OBJECTIVES: In recent years, there has been an increase in skin cancer. The aim of this study was therefore to investigate the representation of skin cancer in public awareness worldwide and in Germany, and to determine whether Skin Cancer Awareness Month is represented in the search interests of the Internet-using population in the same way as Breast Cancer Awareness Month worldwide. DATA AND METHODS: In this study, Google Trends data were used to track levels of public awareness for different tumor entities and skin cancer types worldwide and for Germany...
April 21, 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38642607/deciphering-a-gpcr-lncrna-mirna-nexus-identification-of-an-aberrant-therapeutic-target-in-ovarian-cancer
#18
JOURNAL ARTICLE
Ji Hee Ha, Rangasudhagar Radhakrishnan, Revathy Nadhan, Rohini Gomathinayagam, Muralidharan Jayaraman, Mingda Yan, Srishti Kashyap, Kar-Ming Fung, Chao Xu, Resham Bhattacharya, Priyabrata Mukherjee, Ciro Isidoro, Yong Sang Song, Danny N Dhanasekaran
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies, primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear understanding of disease etiology. Previous studies have identified the pivotal role of Lysophosphatidic acid (LPA)-signaling in ovarian cancer pathobiology. Our earlier transcriptomic analysis identified Urothelial Carcinoma Associated-1 (UCA1) as an LPA-stimulated long non-coding RNA (lncRNA). In this study, we elucidate the tripartite interaction between LPA-signaling, UCA1, and let-7 miRNAs in ovarian cancer progression...
April 18, 2024: Cancer Letters
https://read.qxmd.com/read/38641065/lncrna-serb-promotes-vasculogenic-mimicry-vm-formation-and-tumor-metastasis-in-renal-cell-carcinoma
#19
JOURNAL ARTICLE
Shuai Tang, Fangmin Chen, Jianghui Zhang, Fan Chang, Zheng Lv, Kai Li, Song Li, Yixi Hu, Shuyuan Yeh
A growing body of evidence shows that vasculogenic mimicry (VM) is closely related to the invasion and metastasis of many tumor cells. Although the estrogen receptor (ER) can promote initiation and progression of renal cell carcinoma (RCC), how downstream biomolecules are involved, and the detailed mechanisms of how ER expression is elevated in RCC remain to be further elucidated. Here, we discovered that LncRNA-SERB is highly expressed in tumor cells of RCC patients. We used multiple RCC cells and an in vivo mouse model for our study, and results indicated that LncRNA-SERB could boost RCC VM formation and cell invasion in vitro and in vivo...
April 17, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38640229/gpr1-and-cmklr1-control-lipid-metabolism-to-support-development-of-clear-cell-renal-cell-carcinoma
#20
JOURNAL ARTICLE
Dazhi Wang, Iqbal Mahmud, Vijay S Thakur, Sze Kiat Tan, Daniel G Isom, David B Lombard, Mark L Gonzalgo, Oleksandr N Kryvenko, Philip L Lorenzi, Vanina T Tcheuyap, James Brugarolas, Scott M Welford
Clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, is largely incurable in the metastatic setting. ccRCC is characterized by excessive lipid accumulation that protects cells from stress and promotes tumor growth, suggesting that the underlying regulators of lipid storage could represent potential therapeutic targets. Here, we evaluated the regulatory roles of GPR1 and CMKLR1, two G-protein coupled receptors of the pro-tumorigenic adipokine chemerin that is involved in ccRCC lipid metabolism...
April 19, 2024: Cancer Research
keyword
keyword
95675
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.